Comments

Precigen Stock Price, Quotes and Forecasts

Q: What sector and industry does Precigen (PGEN) operate in?

Precigen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

PGENNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.81

0.010.56%

At close: -

$1.80

-0.01-0.55%

After Hours: Mar 21, 7:17 PM EDT

Q4 2024 Earnings were released on Wed Mar 19th, after the market close

The most recent conference call was at 16:30 PM, 4 days ago Click to view past webcast

Precigen (PGEN) Forecast

News Earnings Precigen (PGEN) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Precigen Stock Price, Quotes and Forecasts | NASDAQ:PGEN | Benzinga

Explore Precigen stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PGEN.

Open	$1.80
Close	$1.81
Volume / Avg.	2.35M / 2.05M
Day Range	$1.78 - $1.96
52 Wk Range	0.65 - 2.17
Market Cap	$527.16M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	11.24%
Days to Cover	9.42

Recent News

Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Friday

Avi Kapoor

Knight-Swift Transportation Posts Upbeat Earnings, Joins TAL Education, LSI Industries, GE Aerospace And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

Precigen Soars: Biologics License Application Submission For PRGN-2012 Targets First FDA-Approved Recurrent Respiratory Papillomatosis Treatment

Precigen submits BLA for PRGN-2012 gene therapy targeting RRP, a rare and life-threatening condition with no cure.

Lekha Gupta

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.80
Close	$1.81
Volume / Avg.	2.35M / 2.05M
Day Range	$1.78 - $1.96
52 Wk Range	0.65 - 2.17
Market Cap	$527.16M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	11.24%
Days to Cover	9.42

About Precigen Inc

Sector

Health Care

Industry

Biotechnology

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company desig...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Precigen (PGEN) stock?

You can purchase shares of Precigen (NASDAQ:PGEN) through any online brokerage.

View our list of the best stock brokerages

Who are Precigen (PGEN) competitors?

Other companies in Precigen’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Immatics (NASDAQ:IMTX), Sage Therapeutics (NASDAQ:SAGE) and AnaptysBio (NASDAQ:ANAB).

What is the forecast, or price target, for Precigen (PGEN) stock?

Precigen has a consensus price target of $6.75.

What is the current price for Precigen (PGEN)?

The stock price for Precigen (NASDAQ: PGEN) is $1.8 last updated March 21, 2025 at 7:17 PM EDT.

Does Precigen (PGEN) pay a dividend?

There are no upcoming dividends for Precigen.

When is Precigen (NASDAQ:PGEN) reporting earnings?

Precigen’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is Precigen (PGEN) going to split?

There is no upcoming split for Precigen.

What sector and industry does Precigen (PGEN) operate in?

Precigen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.